Russia plans to start use domestic reference materials in pharma sector

The Russian Parliament (State Duma) has said it will consider establishing the priority of using domestic reference materials in the pharmaceutical industry.

Currently local pharmaceutical manufacturers use such samples to control the quality of drug batches. Now most of the players continue to use the products of the US and European Pharmacopoeias, imported through third countries, however there is a possibility such a situation will change already in the middle-term.

Since March and the beginning of the military conflict between Ukraine and Russia, the official deliveries of US and European pharmacopoeial reference materials to Russia were stopped. They were used by most Russian pharmaceutical manufacturers in daily practice. At that time, the government decided to speed up the development of the Russian base.